This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Early Savings Deadline Expires In:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event
May 9-12, 2022Hynes Convention Center, Boston

Michael Pennington, PhD
Chief Scientific Officer at AmbioPharm, Inc.

Profile

CSO for AmbioPharm Inc. 2018-present CEO for Peptides International 2010-2018 COO for Bachem Bioscience Inc. 2000-2010 Group Director for R&D Bachem Bioscience 1989-2000 Senior Scientist, Schering Plough 1988-1989 1988 University of Florida Gainesville PhD in Biochemistry and Molecular Biology 1984University of North Carolina Chapel Hill BS Chemistry